Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)
Expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and …
Expert laboratory and clinical researchers from around the world review how to design and evaluate studies of tumor markers and examine their use in breast cancer patients. The authors cover both the major advances in sophisticated molecular methods and the state-of-the-art in conventional prognostic and predictive indicators. Among the topics discussed are the relevance of rigorous study design and guidelines for the validation studies of new biomarkers, gene expression profiling by tissue microarrays, adjuvant systemic therapy, and the use of estrogen, progesterone, and epidermal growth factor receptors as both prognostic and predictive indicators. Highlights include the evaluation of HER2 and EGFR family members, of p53, and of UPA/PAI-1; the detection of rare cells in blood and marrow; and the detection and analysis of soluble, circulating markers.
Ebook rating average
Related Books to : Biomarkers in Breast Cancer (Cancer Drug Discovery and Development)
Related PDF Documents
Contact their sites if you have any question about their content.
biomarker discovery, development and analysis that requires a combination of ... Some examples of cancer biomarkers that are also drug targets, or which can ... receptor negative breast cancer primary cell lines, 8750 identified and 7800...
TeaserCrisis of pharmaceutical industry prompts Research and Development (R&D) focus ... clinically approved for patient stratification in breast cancer.
Technological advancement and the discovery of various biomarkers have made ... targeted many deregulated pathways for the development of specific cancer therapeutics, making the practice of precision medicine a reality for cancer patients. With the exploration ... mone receptor-positive breast cancer patients . Tumor...